Drug Combinations for Dyslipidemia and Obesity Treatment in Metabolic Syndrome

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|15|29|3446-3462

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.29, 2009-10, pp. : 3446-3462

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Treatment of Metabolic Syndrome

By  

Current Clinical Pharmacology, Vol. 8, Iss. 3, 2013-08 ,pp. : 224-231

Bentham Science Publishers

Access to resources Recommend Favorite

Dyslipidemia in the metabolic syndrome

By Chan Dick   Watts Gerald  

The Journal of Drug Evaluation, Vol. 2, Iss. 1, 2004-01 ,pp. : 3-34

Taylor & Francis Ltd

Access to resources Recommend Favorite

Therapeutic Potential of Targeting the Endocannabinoids: Implications for the Treatment of Obesity, Metabolic Syndrome, Drug Abuse and Smoking Cessation

By  

Current Medicinal Chemistry, Vol. 13, Iss. 22, 2006-09 ,pp. : 2669-2680

Bentham Science Publishers

Access to resources Recommend Favorite

Approaches for the Development of Drugs for Treatment of Obesity and Metabolic Syndrome

By  

Current Pharmaceutical Design, Vol. 22, Iss. 7, 2016-02 ,pp. : 895-903

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacotherapy of Mixed Dyslipidemia in the Metabolic Syndrome

By  

Current Clinical Pharmacology, Vol. 5, Iss. 2, 2010-05 ,pp. : 133-139

Bentham Science Publishers

Access to resources Recommend Favorite